参考文献：

[1]OPATZ S, BAMOPOULOS S A, METZELER K H, et al. 2020. The clinical mutatome of core binding factor leukemia. Leukemia [J], 34: 1553-1562.

[2]GAIDZIK V I, BULLINGER L, SCHLENK R F, et al. 2011. RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group. J Clin Oncol [J], 29: 1364-1372.

[3]E M Heath,S M Chan,M D Minden,T Murphy,L I Shlush,A D Schimmer. Biological and clinical consequences of NPM1 mutations in AML[J]. Leukemia,2017,31(20):

[4]DUPLOYEZ N, WILLEKENS C, MARCEAU-RENAUT A, et al. 2015. Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors. Expert Rev Hematol [J], 8: 43-56.

[5]DOHNER H, ESTEY E, GRIMWADE D, et al. 2017. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood [J], 129: 424-447.

[6]张梦娜,杨艳丽,耿英华,李骏,冯会欣.CEBPA基因突变与急性髓系白血病临床特点及预后关系[J].临床血液学杂志,2021,34(09):659-663.

[7] Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-2405.[J]. Blood,2016,128(3):

[8] Diagnostic Tool for the Identification of MLL Rearrangements Including Unknown Partner Genes[J]. Proceedings of the National Academy of Sciences of the United States of America,2005,102(2):

[9]C Meyer,E Kowarz,J Hofmann,A Renneville,J Zuna,J Trka,R Ben Abdelali,E Macintyre,E De Braekeleer,M De Braekeleer,E Delabesse,M P de Oliveira,H Cavé, et al New insights to the MLL recombinome of acute leukemias[J]. Leukemia,2009,23(8):

[10]De Braekeleer Marc,Morel Frédéric,Le Bris Marie-Josée,Herry Angèle,Douet-Guilbert Nathalie. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia.[J]. Anticancer research,2005,25(3B):

[11]Schoch Claudia,Schnittger Susanne,Klaus Mirjam,Kern Wolfgang,Hiddemann Wolfgang,Haferlach Torsten. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases[J]. Blood,2003,102(7):

[12]HEATH E M, CHAN S M, MINDEN M D, et al. 2017. Biological and clinical consequences of NPM1 mutations in AML. Leukemia [J], 31: 798-807.

[13]CHANDRA P, LUTHRA R, ZUO Z, et al. 2010. Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related cases. Am J Clin Pathol [J], 133: 686-693.

[14]Carl Sanden, Malin Ageberg, Jessica Petersson, Andreas Lennartsson, Urban Gullberg. FORCED EXPRESSION OF THE DEK-NUP214 FUSION PROTEIN PROMOTES PROLIFERATION DEPENDENT ON UPREGULATION OF MTOR[J]. Inventi Impact Cancer,2014,2014:

[15]Díaz-Beyá Marina,Labopin Myriam,Maertens Johan,Alijurf Mahmoud,Passweg Jakob,Dietrich Beelen,Schouten Harry,Socié Gerard,Schaap Nicolaas,Schwerdtfeger Rainer,Volin Liisa,Michallet Mauricette,Polge Emmanuelle,Sierra Jorge,Mohty Mohamad,Esteve Jordi,Nagler Arnon. Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission.[J]. British journal of haematology,2020,189(5):

[16]BILL M, MROZEK K, KOHLSCHMIDT J, et al. 2020. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A. Proc Natl Acad Sci U S A [J], 117: 26340-26346.

[17]Y Chen,H Kantarjian,S Pierce,S Faderl,S O'Brien,W Qiao,L Abruzzo,M de Lima,P Kebriaei,E Jabbour,N Daver,T Kadia,Z Estrov,G Garcia-Manero,J Cortes,F Ravandi. Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation[J]. Leukemia,2013,27(4):

[18]ASADA S, FUJINO T, GOYAMA S, et al. 2019. The role of ASXL1 in hematopoiesis and myeloid malignancies. Cell Mol Life Sci [J], 76: 2511-2523.

[19]Arber Daniel A.,Orazi Attilio,Hasserjian Robert,Thiele Jürgen,Borowitz Michael J.,Le Beau Michelle M.,Bloomfield Clara D.,Cazzola Mario,Vardiman James W.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood,2016,127(20):

[20]LAZAREVIC V L, LABOPIN M, DEPEI W, et al. 2018. Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT). Am J Hematol [J], 93: 31-39.

[21]Marta Sitges,Blanca Boluda,Ana Garrido,Mireia Morgades,Isabel et al. Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols[J]. European Journal of Haematology,2020,105(2):

[22]Hiromi Yamazaki,Mikiko Suzuki,Akihito Otsuki,Ritsuko Shimizu,Emery H. Bresnick,James Douglas Engel,Masayuki Yamamoto. A Remote GATA2 Hematopoietic Enhancer Drives Leukemogenesis in inv(3)(q21;q26) by Activating EVI1 Expression[J]. Cancer Cell,2014,25(4):

[23]Lugthart Sanne,Gröschel Stefan,Beverloo H Berna,Kayser Sabine, et al. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.[J]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2010,28(24):

[24]Tang Jih Luh,Hou Hsin An,Chen Chien Yuan,Liu Chieh Yu et al. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations[J]. Blood,2009,114(26):

[25]Gaidzik Verena I,Bullinger Lars,Schlenk Richard F, et al. RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.[J]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2011,29(10):

[26]Chou Wen Chien,Huang Huai Hsuan,Hou Hsin An,Chen Chien Yuan,Tang Jih Luh,Yao Ming,Tsay Woei,Ko Bor Sheng,Wu Shang Ju,Huang Shang Yi,Hsu Szu Chun,Chen Yao Chang,Huang Yen Ning,Chang Yi Chang,Lee Fen Yu,Liu Min Chih,Liu Chia Wen,Tseng Mei Hsuan,Tien Hwei Fang. Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations[J]. Blood,2010,116(20):

[27]Shuhei Asada,Takeshi Fujino,Susumu Goyama,Toshio Kitamura. The role of ASXL1 in hematopoiesis and myeloid malignancies[J]. Cellular and Molecular Life Sciences,2019,76(13):

[28]Lin Yun,Wang Yaping,Zheng Yi,Wang Zechuan,Wang Yanni,Wang Shaoyuan. Clinical characteristics and prognostic study of adult acute myeloid leukemia patients with ASXL1 mutations.[J]. Hematology (Amsterdam, Netherlands),2020,25(1):

[29]Magali Olivier,Monica Hollstein,Pierre Hainaut. TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use[J]. Cold Spring Harbor Laboratory Press,2010,2(1):

[30]Rücker Frank G.,Schlenk Richard F.,Bullinger Lars,Kayser Sabine,Teleanu Veronica,Kett Helena,Habdank Marianne,Kugler Carla Maria,Holzmann Karlheinz,Gaidzik Verena I.,Paschka Peter,Held Gerhard,von Lilienfeld Toal Marie,Lübbert Michael,Fröhling Stefan,Zenz Thorsten,Krauter Jürgen,Schlegelberger Brigitte,Döhner Hartmut. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome[J]. Blood,2012,119(9):

[31]A Stengel,W Kern,T Haferlach,M Meggendorfer,A Fasan,C Haferlach. The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases[J]. Leukemia,2017,31(3):

[32]Kottaridis P D,Gale R E,Frew M E,Harrison G,Langabeer S E,Belton A A,Walker H,Wheatley K,Bowen D T,Burnett A K,Goldstone A H,Linch D C. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.[J]. Blood,2001,98(6):

[33]丁莎莎,沈宏杰,陈子兴,陈苏宁,岑建农,丁子轩,何军.FLT3-ITD突变数量、长度及水平对急性髓系白血病患者预后的影响[J].中华血液学杂志,2015,36(06):449-454.

刘加军 教授